Don Sawyer

Senior Vice President, Global Market Access · Regeneron Pharmaceuticals

Biopharmaceuticals

Don Sawyer is senior vice president of global market access at Regeneron Pharmaceuticals. He joined in 2024 after leading market access at Stemline Therapeutics and other biotechnology and pharmaceutical businesses.

Last reviewed: Oct 21, 2026

Don Sawyer

Senior Vice President, Global Market Access Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Don Sawyer is senior vice president of global market access at Regeneron Pharmaceuticals. He joined in 2024 after leading market access at Stemline Therapeutics and other biotechnology and pharmaceutical businesses.

Career Highlights

  • Joined Regeneron in 2024.
  • Previously served as senior vice president of market access at Stemline Therapeutics.
  • Has led market access functions at AstraZeneca, Celgene, Bayer, Ironwood and Acceleron.

Professional Journey

Sawyer’s career has centered on pharmaceutical market access. He led the function at AstraZeneca, Celgene and Bayer and also worked in that capacity at the start-up companies Ironwood Pharmaceuticals and Acceleron Pharma.

His most recent position before Regeneron was senior vice president of Market Access at Stemline Therapeutics, part of the Menarini Group. That background spans established pharmaceutical businesses and companies building their commercial capabilities.

He joined Regeneron in 2024 and serves as senior vice president of Global Market Access. His legal and undergraduate education accompanies a career focused on market access leadership across different companies and stages of development.

Education

Sawyer earned a JD from Widener University’s Delaware Law School and a BA from the University of Delaware.